In the first
two weeks of January, the prospects for drug importation to help alleviate high
drug prices in the U.S. are looking good. Before summarizing recent
developments, I’ll just note that millions of Americans who can’t afford
medicines and want to save money continue to use personal drug importation,
despite the federal prohibitions. This includes physically traveling across the
border to buy from Canadian or Mexican pharmacies, through international air
travel, and ordering from international online pharmacies.
Lucia Mueller blogged about an important survey by the Campaign for Personal
Prescription Importation in which 94%
of respondents affirmed that cost is the #1 reason they rely on importation
through international online pharmacies.
Inquirer reported on Americans with Medicare falling through the
cracks on drugs dropped from formularies, particularly when they are prescribed
off-label, facing high costs and looking internationally for relief. As
reported, savings are even greater when Americans buy generic versions
overseas, of drugs that are still under patent domestically.
lot of buzz in Congress, states, and the White House on the issue of drug
importation right now. Hopefully, current laws will be amended this year to
make importation expressly permitted instead of merely tolerated.
(more…)Tagged with: Alex Azar, Daraprim, Donald Trump, Scott Gottlieb
From time to time, we participate in the public policy process by submitting public comments to government agencies requesting them. In May of this year, after introducing the Trump administration’s blue print plan for lowering drug prices, the Department of Health and Human Services (HHS) asked the public to comment on the Trump administration plan and/or make recommendations for lowering drug prices and out-of-pocket prescription costs.
I submitted comments that were laser-focused on PharmacyChecker’s area of greatest expertise, personal drug importation and online pharmacies. My comments clarify why and how properly-verified, international online pharmacies are a lifeline of safe and affordable medicines for Americans.
PharmacyChecker Public Comments to HHS July 13, 2018
The basic recommendations offered in the comments are below:
Tagged with: Donald Trump, FDA, HHS, legalizing personal drug importation
- Under Section 804 (j) of the Food, Drug and Cosmetic Act, the Secretary of Health and Human Services should expressly permit medicine imports for personal use to empower patients seeking affordable medication.
- Per the above, implement the Australian model of making personal drug importation legal with caveats to prohibit personal use imports of controlled drugs, especially prescription narcotics.
- The FDA should end its blanket warning against ordering medicines online, imported for personal use from pharmacies in Canada and other countries, and instead provide guidance on best practices for those who choose to import.
- The FDA should stop seizing personal imports of non-controlled medicines arriving from pharmacies that the FDA knows are licensed and require valid prescriptions.
- The FDA should take no enforcement actions against international online pharmacies that it has reason to believe are the safest international options available to Americans and instead focus on those that represent the gravest threats, particularly ones that sell prescription narcotics.
If you have been watching the news, you’ve likely heard the current administration’s support for affordable healthcare, lower prescription drugs costs, and less red tape around the FDA’s drug approval process. These platform statements are powerful to a country where prescription drug costs are significant. In fact, according to an AARP report from 2015, the price of prescriptions per household amount to more than the average family’s income per year. To many eager constituents, these campaign promises create the illusion of a future of financial stability and an adequate, cost-effective healthcare system that treats people as patients instead of dollar signs. Before we pop the champagne, we need to look at both the current system we are proposing to fix and the actions that the government has already taken against these its original statements.
The Trump administration points the finger at the FDA’s current drug approval process as a major cause for high drug prices. Critics of the existing approval process believe it to be slow, full of unnecessary procedures, and a hindrance to the approval of potentially life-saving drugs. Notice, I said potentially. (more…)
Tagged with: Bernie Sanders, Consumer Safety, Donald Trump, healthcare, Palladone